文献速递免疫规划

经皮免疫用SLA或rLACK诱导Th1应答但未能保护BALB/c小鼠抗硕大利什曼原虫攻击

Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge.
PubMed 文献 · Vaccine · 2018-12-06

研究评估经皮免疫(TCI)以硕大利什曼原虫可溶性抗原(SLA)或重组rLACK抗原联合霍乱毒素(CT)免疫BALB/c小鼠的效果。结果显示TCI诱导了高滴度抗体和Th1型应答,但攻击后rLACK未提供保护,SLA/CT组耳部病变更大、寄生虫负荷更高,且一氧化氮合酶染色减弱。结论为尽管诱导强Th1应答,TCI未能保护小鼠抗硕大利什曼原虫感染。

要点

  • TCI联合CT可诱导高水平的抗SLA、抗rLACK及抗CT IgG抗体。
  • SLA/CT或rLACK/CT免疫诱导Th1型应答,IFN-γ分泌细胞频率高、IFN-γ水平高、IL-10水平低。
  • 攻击后rLACK未保护,SLA/CT组耳部病变更大、寄生虫负荷更高。

核心结论

  • 经皮免疫虽诱导强Th1型免疫应答,但攻击后出现感染加重,未能保护BALB/c小鼠抗硕大利什曼原虫。

研究设计与样本

  • BALB/c小鼠在第1、4、7周经皮免疫PBS、CT、SLA/CT或rLACK/CT,末次加强后2周检测免疫指标,其余小鼠耳部皮内攻击5×10^4个硕大利什曼原虫后肢前鞭毛体,每周监测,7周后处死评估寄生虫负荷和耳部病变免疫组织病理。

主要发现

  • SLA/CT或rLACK/CT免疫小鼠产生高水平的抗SLA、抗rLACK和抗CT IgG抗体。
  • SLA/CT或rLACK/CT免疫小鼠显示Th1型应答:IFN-γ分泌细胞频率高、IFN-γ水平高、IL-10水平低,IFN-γ/IL-10比值高。
  • 攻击后rLACK免疫未与保护相关。
  • SLA/CT免疫小鼠耳部病变更大,耳部寄生虫负荷增加。
  • 耳部活检一氧化氮合酶染色强度在SLA/CT组较对照组减弱,提示感染部位寄生虫杀伤减少。

临床怎么用

  • 经皮免疫诱导Th1应答不等同于保护,疫苗评估需结合攻击后寄生虫负荷和病变程度。
  • SLA/CT经皮免疫可能加重硕大利什曼原虫感染,提示需谨慎评估该策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Leishmaniasis is an expanding health threat worldwide complicated by the absence of an effective vaccine. We investigated transcutaneous immunization (TCI) as a needle-free immunization route which exploits the abundance of antigen presenting cells in the skin to induce both mucosal and systemic immunity. Leishmania (L.) major soluble antigens (SLA) or recombinant Leishmania homolog of receptors for activated C-kinase (rLACK) antigens were delivered transcutaneously together with cholera toxin (CT), to BALB/c mice. Mice were immunized at weeks 1, 4, and 7 with PBS, CT, SLA/CT or rLACK/CT. Two weeks after the final boost, antigen-specific IgG titers, IFN-γ ELISpot, and cytokine levels were assessed in half of the mice and the remainder were challenged with an intradermal (ear) injection of 5 × 104L. major metacyclic parasites. Mice were monitored weekly and sacrificed after 7 weeks to assess the parasite burden and to study the ear lesion immunohistopathology. Our results show that TCI with SLA or rLACK yielded high levels of anti-SLA, anti-rLACK and anti-CT IgG antibodies. A Th1-type of immune response was demonstrated with a high frequency of IFN-γ secreting cells, high levels of IFN-γ production, and lower levels of IL-10 resulting in a high IFN-γ/IL-10 ratio in mice immunized with SLA/CT or rLACK/CT. After parasite challenge, rLACK immunization was not associated with protection. In addition, SLA/CT immunized mice had larger ear lesions and an increased parasite load in the ear. Immunohistochemistry of ear biopsies stained for nitric oxide synthase revealed that staining intensity was diminished in the SLA/CT group compared to the control group. This finding suggested that less parasite killing occurred at the site of the infection. In conclusion, despite a strong Th1 type profile induced by TCI, exacerbation of infection occurred after challenge with L. major. This also correlated with low induction of nitric oxide.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lakhal-Naouar I, Koles N, Rao M, et al. Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge. Vaccine. 2018. PMID: 30528328. doi:10.1016/j.vaccine.2018.11.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。